Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease

Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease

Background and aims: Oxidative stress (OS) induces the production of fibroblast growth factor 21 (FGF21). Previous data have revealed that FGF21 protects cells from OS injury and death, making it a potential therapeutic option for many diseases with increased OS. However, the association of this gro...

Full description

Bibliographic Details
Main Authors: Gómez-Sámano Miguel Ángel, Vargas-Abonce Valerie Paola, Martínez-Sánchez Froylan David, Palacios-Báez Lucía, Vera-Zertuche Juan Mauricio, Navarro-Flores María Fernanda, Morales-García Mariana Guadalupe, Fonseca-Correa Jorge Ignacio, Zuarth-Vázquez Julia María, Vega-Vega Olynka, Correa-Rotter Ricardo, Rincón-Pedrero Rodolfo, Morales-Buenrostro Luis E., Alberú-Gómez Josefina, Ramírez-González Julia Berenice, Pacheco-Domínguez Reyna Lizette, López-Cervantes Malaquías, Mendoza-de-la-Garza María de los Ángeles, Baeza-Arias Yolanda Victoria, Espinosa-Cuevas Ángeles, López-Carrasco Guadalupe, López-Estrada Angelina, Guillén-Pineda Luz Elizabeth, Gómez-Pérez Francisco J., Cuevas-Ramos Daniel
Format: Article
Language:English
Published: SAGE Publishing 2021-03-01
Series:Therapeutic Advances in Endocrinology and Metabolism
Online Access:https://doi.org/10.1177/20420188211001160

Internet

https://doi.org/10.1177/20420188211001160

Similar Items